Modelling to estimate the health impact of novel tuberculosis vaccines on TB burden in people living with HIV
Creating evidence to support tuberculosis (TB) national and global decision-makers in reducing the global burden of TB
Potential implications of reduced tuberculosis vaccine efficacy in those with undernutrition on overall vaccine impact in India
The implications of using different time horizons when evaluating investment to prevent infectious disease
New tuberculosis vaccines are in late-stage trials, but how confident is the public in high burden countries in vaccines?
